The Correlation between Intensification of Antihypertensive Regimens and Therapeutic Adherence with Blood Pressure Control and Lipid Profiles in Patients with Chronic Hypertension at Ben Mboi General Hospital in Kupang

Share this article Share via WhatsApp

Article metrics

OJS usage and citation sources
Abstract views55OJS
Article downloads63OJS
Crossref citations—Unavailable
Google Scholar citations—Not verified

Views and downloads are recorded by OJS; statistics processing may be delayed. A dash means the source count is unavailable. Search Google Scholar

Main Article Content

Wayan Agus Wijaya
Phebe Hendra

Abstract

Hypertension is a major public health issue with a high prevalence in Indonesia and is often accompanied by dyslipidemia, which increases cardiovascular risk. This study aims to analyze the relationship between the intensification of antihypertensive regimens and treatment adherence, and their effects on blood pressure control and lipid profiles in patients with chronic hypertension at Ben Mboi General Hospital in Kupang. The subjects were predominantly female (61%) and under 60 years old (66%). The study used a retrospective cohort design based on medical record data of chronic hypertension patients from January to December 2025 and The research sample consisted of 100 patients. All subjects (100%) were classified as compliant with a mean Medication Possession Ratio (MPR) of 0.84±0.02; 88% of patients received therapy intensification (mean Therapeutic Intensity Score 0.08±0.27). The mean blood pressure was 128.00 ± 1.64/79.86 ± 2.12 mmHg, and all subjects had their blood pressure under control. Meanwhile, 12% of subjects had cholesterol levels within the normal range, and all subjects had triglyceride levels within the normal range. The Spearman test showed no significant relationship between MPR or TIS and systolic blood pressure, diastolic blood pressure, total cholesterol, and triglycerides (p-values ranged from 0.340 to 0.808). There was no significant relationship between adherence and therapy intensification and blood pressure control or lipid profiles, likely due to a ceiling effect, as all subjects were already in a controlled condition. The ceiling effect occurs when nearly all subjects fall into the same category for both variables (100% compliant and 100% controlled), resulting in very low data variability that prevents the correlation test from detecting a relationship, regardless of whether such a relationship exists clinically.

Article Details

Section

Original Articles

How to Cite

The Correlation between Intensification of Antihypertensive Regimens and Therapeutic Adherence with Blood Pressure Control and Lipid Profiles in Patients with Chronic Hypertension at Ben Mboi General Hospital in Kupang. (2026). Journal of Pharmaceutical and Sciences, 9(4), 3509-3520. https://doi.org/10.36490/journal-jps.com.v9i4.1753

References

[1] World Health Organization. Hypertension 2023. https://www.who.int/news-room/fact-sheets/detail/hypertension (accessed September 25, 2025).

[2] Muharram FR, Widyahening IS, Danaei G. Hypertension care performance in Indonesia : evidence from three waves of nationally representative cross- ¬ sectional surveys 2025:1–9. https://doi.org/10.1136/bmjopen-2025-109588.

[3] Kementerian Kesehatan Republik Indonesia. Laporan Riskesdas 2018 Nasional. Jakarta: badan penelitian dan pengembangan kesehatan; 2019.

[4] Maghfiroh QY, Sawitri E, Herdianto D. The Relationship between Hypertension and Dyslipidemia with Degree of Coronary Stenosis in Patients with Coronary Artery Disease at Abdoel Wahab Sjahranie Hospital in Samarinda 2025;8:29–36.

[5] Berberich AJ, Hegele RA. Review A Modern Approach to Dyslipidemia 2022;43:611–53. https://doi.org/https://doi.org/10.1210/endrev/bnab037.

[6] Thongtang N, Sukmawan R, Llanes EJB, Lee ZV. Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices. Preventive Medicine Reports 2022;27:101819. https://doi.org/10.1016/j.pmedr.2022.101819.

[7] Morales-Villegas EC, Yarleque C, Almeida ML. Management of hypertension and dyslipidemia in Mexico: evidence, gaps, and approach. Archivos de Cardiologia de Mexico 2023;93:77–87. https://doi.org/10.24875/ACM.21000330.

[8] Kim BJ, Cho YJ, Hong KS, Lee J, Kim JT, Choi KH, Park TH, Park SS, Park JM, Kang K, Lee SJ, Kim JG, Cha JK, Kim DH, Lee BC, Yu KH, Oh MS, Kim DE, Ryu WS, Choi JC, Kim WJ, Shin DI, Sohn S Il, Hong JH, Lee JS, Lee J, Han MK, Gorelick PB, Bae HJ. Treatment intensification for elevated blood pressure and risk of recurrent stroke. Journal of the American Heart Association 2021;10. https://doi.org/10.1161/JAHA.120.019457.

[9] Derington CG, Bress AP, Moran AE, Weintraub WS, Herrick JS, Cushman WC, Kronish IM, Stults B, Shimbo D, Muntner P, Greene T, Bates JT, Chang TI, Katz LA, Rehman SU, Roumie CL, Tamariz L, King JB. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. Hypertension 2023;80:590–7. https://doi.org/10.1161/HYPERTENSIONAHA.122.20373.

[10] Anugera AI, Setiawan CH. Effect of Antihypertensive Therapy Compliance Using Medication Possession Ratio Method on Blood Pressure in Patients with Hypertension. Journal of Pharmaceutical Sciences and Community 2022;19:15–22. https://doi.org/10.24071/jpsc.003672.

[11] Wulanjari G, Murtisiwi L, Khasanah RN. The association between medication adherence level with success of therapy in hypertension patients. Indonesian Journal of Global Health Research 2019;2:419–26. https://doi.org/10.37287/ijghr.v2i4.250.

[12] Sumiasih H, Utami W, Kesehatan P, Setya B, Yogyakarta I, Studi P, Fakultas F, Semarang UD. Hubungan Kepatuhan Minum Obat terhadap Keberhasilan Terapi pada Pasien Hipertensi di Puskesmas Prambanan Sleman Bulan Januari – Februari 2020 2020;11:21–7.

[13] Wan KS, Moy FM, Mohd Yusoff MF, Mustapha F, Ismail M, Mat Rifin H, Yoga Ratnam KK, Ismail H, Chong KK, Ahmad NA, Hairi NN. Treatment intensification and therapeutic inertia of antihypertensive therapy among patients with type 2 diabetes and hypertension with uncontrolled blood pressure. Scientific Reports 2024;14:1–10. https://doi.org/10.1038/s41598-024-63617-4.

[14] Perhi. Konsensus Penatalaksanaan Hipertensi 2019. Indonesian Society Hipertensi Indonesia 2019:1–90.

[15] Schwinghammer TL, DiPiro JT, Ellingrod VL, DiPiro C V. Dipiro, J. T., DiPiro, C. V., Schwinghammer, T. L., & Wells, B. G. (2015). Pharmacotherapy handbook. McGraw-hill. 2021.

[16] Amarudin IL, M ErnaF, P FanceR, G MariaY. Metodologi Penelitian Kuantitattif dan Kualitatif. Bandung, Jawa Barat: CV Media Sains Indonesia; 2022.

[17] Abdullah A, Hanif M, Shamim AA, Hossain M, Hasan M, Khan SA, Hossaine M, Ullah MA, Sarker SK, Rahman SMM, Mitra DK, Mridha MK. specific prevalence and associated factors of hypertension among elderly Bangladeshi people : findings from a nationally representative cross- ¬ sectional survey 2021:1–12. https://doi.org/10.1136/bmjopen-2020-038326.

[18] Ravindrarajaha R, Dregana A, B NCH, Hamadaa S, Stephen H.D. Jacksonc, Martin C. and Gulliforda B. Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records. Journal of Hypertension 2017;35:1276–82. https://doi.org/10.1097/HJH.0000000000001291.

[19] Prihatin K, Fatmawati BR, Suprayitna M. Faktor Faktor Yang Mempengaruhi Kepatuhan Berobat Penderita 2020;10:7–16.

[20] Albadrani MS, Aljeelani YO, Farsi SH, Aljohani MA, Tobaiqi MAA, Aljohani AM, Alzaman NS. Effect of medication adherence on quality of life , activation measures , and health imagine in the elderly people : a cross- sectional study 2024:1–10.

[21] Sinuraya RK, Destiani DP, Puspitasari IM, Diantini A, Farmakologi D, Farmasi F, Padjadjaran U. Tingkat Kepatuhan Pengobatan Pasien Hipertensi di Fasilitas Kesehatan Tingkat Pertama di Kota Bandung Medication Adherence among Hypertensive Patients in Primary Healthcare in Bandung City 2018;7. https://doi.org/10.15416/ijcp.2018.7.2.124.

[22] Matematica D, Milano P, Bonardi V, Rea F, Savaré L, Franchi M, Corrao G, Mancia G. Adherence to Treatment by Initial Antihypertensive Mono and Combination Therapies Adherence to Treatment by Initial Antihypertensive Mono and Combination Therapies 2022. https://doi.org/10.1093/ajh/hpab083.

[23] Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bress AP, Carter J, Commodore-Mensah Y, Egan B, Melnyk BM, Ogunniyi MO, Schott SL, Watson KE, Williamson JD, Jones DW, Ferdinand KC, Taler SJ, Bansal N, Bello NA, Cohen JB, Collins KJ, Davis LL, Khan SS, Lloyd-Jones DM, Mistry EA, Smith SC, Talbot AW, Vongpatanasin W, Whelton PK. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee . vol. 82. 2025. https://doi.org/10.1161/HYP.0000000000000249.

[24] McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM, Abreu A, Olsen MH, Ambrosetti M, Androulakis E, Bang LE, Bech JN, Borger MA, Boutouyrie P, Bronze L, Buccheri S, Dalmau R, De Pablo Zarzosa MC, Delles C, Fiuza MM, Gabulova R, Haugen BO, Heiss C, Ibanez B, James S, Kapil V, Kayikçioglu M, Køber L, Koskinas KC, Locati ET, MacDonald S, Mihailidou AS, Mihaylova B, Mindham R, Mortensen MB, Nardai S, Neubeck L, Nielsen JC, Nilsson PM, Pasquet AA, Pedro MM, Prescott E, Rakisheva A, Rietzschel E, Rocca B, Rossello X, Schmid JP, Shantsila E, Sudano I, Timóteo AT, Tsivgoulis G, Ungar A, Vaartjes I, Visseren F, Voeller H, Vrints C, Witkowski A, Zennaro MC, Zeppenfeld K, Shuka N, Laredj N, Pavo N, Mirzoyev U, van De Borne P, Sokolović Š, Postadzhiyan A, Samardzic J, Agathangelou P, Widimsky J, Olsen MH, El-Kilany WM, Pauklin P, Laukkanen JA, Boulestreau R, Tsinamdzgvrishvili B, Kintscher U, Marketou M, Páll D, Hrafnkelsdóttir PJ, Dolan E, Wolak T, Bilo G, Tundybayeva MK, Mirrakhimov E, Trusinskis K, Kiwan G, Msalem O, Badarienė J, Banu CA, Balbi MM, Caraus A, Boskovic A, Mouine N, Vromen T, Bosevski M, Midtbø HB, Doroszko A, Dores H, Badila E, Bini R, Simić DV, Fras Z, Mazón P, Spaak J, Burkard T, Barakat E, Abdessalem S, Gunes Y, Sirenko YM, Brady AJB, Khamidullaeva GA, Arbelo E, Baigent C, McEvoy JW. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal 2024;45:3912–4018. https://doi.org/10.1093/eurheartj/ehae178.

[25] Aditya M, Siwi A, Nadhiroh L, Widara RT, Kunci K. Hubungan antara Kepatuhan Minum Obat dengan Tekanan Darah pada Pasien Hipertensi di Fasilitas Kesehatan Tingkat Pertama © 2022 Program Studi S-1 Kesehatan Masyarakat Universitas Muhammadiyah Semarang 2024;19:14–9.

[26] Aldo Falendra Priyono, Ade Utia Detty, Resti Arania, Rina Kriswiastiny. Gambaran Profil Lipid Pada Pasien Hipertensi Berdasarkan Umur Lansia Di Rsud Dr. H. Abdul Moeloek Provinsi Lampung. Jurnal Ilmu Kedokteran Dan Kesehatan 2023;10:2686–93.